© Drug Hunter Inc. 2018-2023
Home > EB-42486
oral G2019S-LRRK2 mut.-selective kinase inh.
>70x sel. for ParkinsonÕs mut. over WT, non-BP
from 50k cmpd HTS + homology-based opt.
J. Med. Chem., Nov. 16, 2020
ESCAPE Bio, South San Francisco, CA
EB-42486 (ESCAPE Bio oral G2019S-LRRK2 mutant-selective kinase inhibitor)
You don’t have time to read everything, but you can’t afford to fall behind.
Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.
Get ahead now by requesting a trial.
Molecules of the Month
Molecule of the Year